ACHP, CAS [[406208-42-2]]

Artikelnummer: TGM-T22021
Artikelname: ACHP, CAS [[406208-42-2]]
Artikelnummer: TGM-T22021
Hersteller Artikelnummer: T22021
Alternativnummer: TGM-T22021-1MG,TGM-T22021-5MG,TGM-T22021-10MG,TGM-T22021-25MG,TGM-T22021-50MG,TGM-T22021-100MG,TGM-T22021-200MG,TGM-T22021-500MG
Hersteller: TargetMol
Kategorie: Biochemikalien
Alternative Synonym: IKK-2 Inhibitor VIII
ACHP (IKK-2 Inhibitor VIII) is a novel selective and potent IKK inhibitor with inhibitory effects on IKK-alpha and IKK-beta. ACHP has anti-HIV-1 activity and inhibits HIV-1 long terminal repeat (LTR)-driven gene expression through inhibition of NF-kappaB activation, inhibits TNF-alpha-induced NF-kappaB (p65) recruitment to the HIV-1 LTR, and inhibits TNF-alpha-induced NF-kappaB (p65) recruitment to the HIV-1 LTR. ACHKP has anti-HIV-1 activity and inhibits TNF-alpha-induced recruitment of NF-kappaB (p65) to the HIV-1 LTR.
Molekulargewicht: 364.44
Reinheit: 98.77%
CAS Nummer: [406208-42-2]
Formel: C21H24N4O2
Target-Kategorie: IkappaB/IKK|||Apoptosis|||STAT
T22021